Cargando…

SARS-CoV-2 infection in patients with autoimmune hepatitis

BACKGROUND & AIMS: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) continues to have a devastating impact across the globe. However, little is known about the disease course in patients with autoimmune hepatitis (AIH). METHODS: Data for patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marjot, Thomas, Buescher, Gustav, Sebode, Marcial, Barnes, Eleanor, Barritt, A. Sidney, Armstrong, Matthew J., Baldelli, Luke, Kennedy, James, Mercer, Carolyn, Ozga, Ann-Kathrin, Casar, Christian, Schramm, Christoph, Moon, Andrew M., Webb, Gwilym J., Lohse, Ansgar W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835076/ https://www.ncbi.nlm.nih.gov/pubmed/33508378 http://dx.doi.org/10.1016/j.jhep.2021.01.021

Ejemplares similares

SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes
por: Baldelli, Luke, et al.
Publicado: (2023)

Determining risk factors for mortality in liver transplant patients with COVID-19
por: Webb, Gwilym J, et al.
Publicado: (2020)

Age and comorbidity are central to the risk of death from COVID-19 in liver transplant recipients
por: Webb, Gwilym J., et al.
Publicado: (2021)

Prevalence of COVID‐19 in patients with autoimmune liver disease in Europe: A patient‐oriented online survey
por: Zecher, Britta Franziska, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
por: Marjot, Thomas, et al.
Publicado: (2021)

COVID-19 and liver transplantation: the jury is still out – Authors' reply
por: Webb, Gwilym J, et al.
Publicado: (2021)

“Autoimmune(-Like)” Drug and Herb Induced Liver Injury: New Insights into Molecular Pathogenesis
por: Sebode, Marcial, et al.
Publicado: (2017)

Autoimmune hepatitis and COVID-19: No increased risk for AIH after vaccination but reduced care
por: Rüther, Darius Ferenc, et al.
Publicado: (2022)

Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
por: Steinmann, Silja, et al.
Publicado: (2023)

COVID-19 and liver disease: mechanistic and clinical perspectives
por: Marjot, Thomas, et al.
Publicado: (2021)

Autoantibodies in Autoimmune Liver Disease—Clinical and Diagnostic Relevance
por: Sebode, Marcial, et al.
Publicado: (2018)

Inflammatory Phenotype of Intrahepatic Sulfatide-Reactive Type II NKT Cells in Humans With Autoimmune Hepatitis
por: Sebode, Marcial, et al.
Publicado: (2019)

SARS‐CoV‐2 Infections Among Patients With Liver Disease and Liver Transplantation Who Received COVID‐19 Vaccination
por: Moon, Andrew M., et al.
Publicado: (2021)

SARS‐CoV‐2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease
por: Duengelhoef, Paul, et al.
Publicado: (2022)

Failure of thymic deletion and instability of autoreactive Tregs drive autoimmunity in immune-privileged liver
por: Preti, Max, et al.
Publicado: (2021)

New foe treated with old guns – supportive role of steroids in the treatment of acute severe hepatitis E
por: Sebode, Marcial, et al.
Publicado: (2014)

Tolerance and autoimmunity in the liver
por: Schramm, Christoph, et al.
Publicado: (2022)

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
por: Webb, Gwilym J, et al.
Publicado: (2020)

High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry
por: Moon, Andrew M., et al.
Publicado: (2020)

Metamizole: An underrated agent causing severe idiosyncratic drug‐induced liver injury
por: Sebode, Marcial, et al.
Publicado: (2020)

Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure
por: Zenouzi, Roman, et al.
Publicado: (2018)

Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
por: Peiseler, Moritz, et al.
Publicado: (2018)

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
por: Marjot, Thomas, et al.
Publicado: (2021)

High-Throughput Immunogenetics Reveals a Lack of Physiological T Cell Clusters in Patients With Autoimmune Cytopenias
por: Simnica, Donjete, et al.
Publicado: (2019)

The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude
por: Webb, Gwilym J., et al.
Publicado: (2021)

Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
por: Ehlken, Hanno, et al.
Publicado: (2016)

Single-cell atlas of hepatic T cells reveals expansion of liver-resident naive-like CD4(+) T cells in primary sclerosing cholangitis
por: Poch, Tobias, et al.
Publicado: (2021)

Humoral and cellular immune responses to wild-type and omicron (B.1.1.529) SARS-CoV-2 variants following a fourth COVID-19 vaccination in liver transplant recipients and patients with autoimmune hepatitis
por: Dimitriadis, Stavros, et al.
Publicado: (2022)

Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019
por: Wang, Tingyan, et al.
Publicado: (2021)

B cells in autoimmune hepatitis: bystanders or central players?
por: Schultheiß, Christoph, et al.
Publicado: (2022)

Features and outcome of AIH patients without elevation of IgG
por: Hartl, Johannes, et al.
Publicado: (2020)

Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022
por: de Kleine, Ruben H, et al.
Publicado: (2022)

The rs738409 G Allele in PNPLA3 Is Associated With a Reduced Risk of COVID-19 Mortality and Hospitalization
por: Innes, Hamish, et al.
Publicado: (2021)

Management of patients with autoimmune liver disease during COVID-19 pandemic
por: Lleo, Ana, et al.
Publicado: (2020)

Severe refractory warm autoimmune haemolytic anaemia after the SARS-CoV-2 Pfizer-BioNTech vaccine (BNT162b2 mRNA) managed with emergency splenectomy and complement inhibition with eculizumab
por: Jackson, Emma Marguerite, et al.
Publicado: (2022)

Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis
por: Schultheiß, Christoph, et al.
Publicado: (2023)

Elevated Liver Enzymes in Patients with COVID-19: Look, but Not Too Hard
por: Moon, Andrew M., et al.
Publicado: (2020)

Confidence in treatment is contributing to quality of life in autoimmune liver diseases. The results of ERN RARE‐LIVER online survey
por: Wunsch, Ewa, et al.
Publicado: (2022)

IFNγ and CTLA-4 Drive Hepatic CD4 T-Cell Tolerance and Protection From Autoimmunity in Mice
por: Krzikalla, Daria, et al.
Publicado: (2023)

Review article: role of glucagon‐like peptide‐1 receptor agonists in non‐alcoholic steatohepatitis, obesity and diabetes—what hepatologists need to know
por: Barritt, A. Sidney, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_krhj9sh3e8pcu5esu6fb6vc1so